MX9702252A - Nuevos androstanos para inducir efectos hipotalamicos. - Google Patents
Nuevos androstanos para inducir efectos hipotalamicos.Info
- Publication number
- MX9702252A MX9702252A MX9702252A MX9702252A MX9702252A MX 9702252 A MX9702252 A MX 9702252A MX 9702252 A MX9702252 A MX 9702252A MX 9702252 A MX9702252 A MX 9702252A MX 9702252 A MX9702252 A MX 9702252A
- Authority
- MX
- Mexico
- Prior art keywords
- androstans
- induce
- new
- hypothalamic effects
- hypothalamic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0007—Androstane derivatives not substituted in position 17
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0055—Estrane derivatives not substituted in position 17
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
- C07J13/002—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 13 (17)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
- C07J13/005—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 16 (17)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
- C07J13/007—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 17 (20)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
- C07J75/005—Preparation of steroids by cyclization of non-steroid compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Steroid Compounds (AREA)
Abstract
La invencion se relaciona con nuevos esteroides androstanos que son semiquímicos ligandos que se unen a receptores neuroepiteliales.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/316,435 US5969168A (en) | 1991-01-07 | 1994-09-29 | Androstanes for inducing hypothalamic effects |
| US08316435 | 1994-09-29 | ||
| PCT/US1995/012538 WO1996010031A1 (en) | 1994-09-29 | 1995-09-29 | Novel androstanes for inducing hypothalamic effects |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MXPA97002252A MXPA97002252A (es) | 1997-06-01 |
| MX9702252A true MX9702252A (es) | 1997-06-28 |
Family
ID=23229039
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9702252A MX9702252A (es) | 1994-09-29 | 1995-09-29 | Nuevos androstanos para inducir efectos hipotalamicos. |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US5969168A (es) |
| EP (1) | EP0783512A4 (es) |
| JP (1) | JPH10509692A (es) |
| KR (1) | KR970706296A (es) |
| CN (1) | CN1057767C (es) |
| AU (1) | AU702704B2 (es) |
| BR (1) | BR9509173A (es) |
| CA (1) | CA2199043A1 (es) |
| CZ (1) | CZ92597A3 (es) |
| FI (1) | FI971314L (es) |
| HU (1) | HUT77665A (es) |
| MX (1) | MX9702252A (es) |
| NO (1) | NO971418L (es) |
| NZ (1) | NZ294508A (es) |
| PL (1) | PL319606A1 (es) |
| RU (1) | RU2160740C2 (es) |
| WO (1) | WO1996010031A1 (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE255898T1 (de) * | 1993-06-15 | 2003-12-15 | Pherin Corp | Androstansteroide als neurochemische initiatoren einer veränderung der hypothalamusfunktion beim menschen und verwandte pharmazeutische präparate und verfahren |
| US6066627A (en) * | 1994-08-04 | 2000-05-23 | Pherin Corporation | Steroids as neurochemical initiators of change in human blood levels of LH |
| CN1167489A (zh) * | 1994-09-29 | 1997-12-10 | 弗伦有限公司 | 具有诱导下丘脑作用的新的雌甾烯 |
| DE19509729A1 (de) * | 1995-03-13 | 1996-09-19 | Schering Ag | 17-Difluormethylen-Estratriene |
| US5922699A (en) * | 1996-06-07 | 1999-07-13 | Pherin Corporation | 19-nor-cholane steroids as neurochemical initiators of change in human hypothalamic function |
| CA2260253A1 (en) * | 1996-07-23 | 1998-01-29 | Clive L. Jennings-White | Steroids as neurochemical stimulators of the vno to alleviate symptoms of pms and anxiety |
| US20030045514A1 (en) * | 2001-05-03 | 2003-03-06 | Louis Monti | 17-Methyleneandrostan-3alpha-ol analogs as CRH inhibitors |
| US20040072814A1 (en) | 2002-10-11 | 2004-04-15 | Solvay Pharmaceuticals Gmbh | Method for obtaining a natural mixture of conjugated equine estrogens depleted in non-conjugated lipophilic compounds |
| AR041121A1 (es) * | 2002-10-11 | 2005-05-04 | Solvay Pharm Gmbh | Procedimiento para la obtencion de una mezcla natural de estrogenos conjugados |
| US8309539B2 (en) * | 2005-09-09 | 2012-11-13 | Pherin Pharmaceuticals, Inc. | Acute treatment of social phobia |
| CN112778390B (zh) * | 2021-01-22 | 2022-09-30 | 厦门欧瑞捷生物科技有限公司 | 一种雄烯酮的合成方法 |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2846451A (en) * | 1953-12-11 | 1958-08-05 | Syntex Sa | Cyclopentanophenanthrene derivatives and process |
| US3043836A (en) * | 1961-05-02 | 1962-07-10 | Searle & Co | 13beta-carboxy-17beta-hydroxy-10beta-methylgon-4-en-3-one, derivatives thereof and intermediates thereto |
| GB976215A (en) * | 1962-03-15 | 1964-11-25 | Searle & Co | Improvements in or relating to steroids |
| US3264327A (en) * | 1962-07-27 | 1966-08-02 | Syntex Corp | 17alpha-fluoro-, 17beta-chlorofluoroacetoxy- and 17beta-methyl-delta4-and delta5-androstene derivatives |
| US3281436A (en) * | 1964-08-05 | 1966-10-25 | Abbott Lab | Process for making gem-difluorosteroids |
| US3413321A (en) * | 1966-06-03 | 1968-11-26 | Du Pont | Selected 17-fluoro-delta16 steroids |
| US3470216A (en) * | 1966-11-29 | 1969-09-30 | Du Pont | Selected 17,17-difluoro unsaturated androstanes |
| GB1175219A (en) * | 1967-06-22 | 1969-12-23 | Ici Ltd | 3-Aminoalkoxycarbonylmethylene Steroid Derivatives |
| US3681490A (en) * | 1969-07-22 | 1972-08-01 | Nat Res Dev | Artificial insemination of pigs |
| DE2336432A1 (de) * | 1973-07-13 | 1975-01-30 | Schering Ag | 3.17.18-trihydroxy-1.3.5(10)-oestratriene |
| FR2255313B1 (es) * | 1973-12-20 | 1976-10-08 | Gole Jean | |
| US4239681A (en) * | 1974-04-15 | 1980-12-16 | Richardson-Merrell Inc. | Androst-4-en-19-ols |
| US4139617A (en) * | 1974-05-13 | 1979-02-13 | Richardson-Merrell Inc. | 19-Oxygenated-androst-5-enes for the enhancement of libido |
| US4022769A (en) * | 1974-05-13 | 1977-05-10 | Richardson-Merrell Inc. | Androst-4-en-19-ones |
| US4071625A (en) * | 1974-05-13 | 1978-01-31 | Richardson-Merrell Inc. | 19-Oxygenated-5α-androstanes for the enhancement of libido |
| GB1550343A (en) * | 1975-07-16 | 1979-08-15 | Gist Brocades Nv | Androstane derivatives |
| DE2758549A1 (de) * | 1977-12-23 | 1979-07-05 | Schering Ag | Pharmazeutische zubereitung |
| US4133811A (en) * | 1978-02-17 | 1979-01-09 | E. R. Squibb & Sons, Inc. | 13-Alkylthio (and arylthio)-11,17-epoxy-17-methyl-18-norandrostenes |
| US4212815A (en) * | 1978-07-05 | 1980-07-15 | E. I. Du Pont De Nemours And Company | Preparation of vinylene fluorides |
| US4425339A (en) * | 1981-04-09 | 1984-01-10 | Syntex (U.S.A.) Inc. | Treatment of menopausal symptoms |
| US4349474A (en) * | 1981-07-27 | 1982-09-14 | G. D. Searle & Co. | 2-Cyanosteroids |
| US5155045A (en) * | 1985-01-25 | 1992-10-13 | Trustees Of The University Of Penn. | Use of male essence to alter female endocrine response |
| US4863911A (en) * | 1986-08-04 | 1989-09-05 | University Of Florida | Method for treating male sexual dysfunction |
| US4835147A (en) * | 1987-05-06 | 1989-05-30 | City Of Hope | Dehydroepiandrosterone therapy for ameleoration of prostate hypertrophy and sexual dysfunction |
| CA2425849C (en) * | 1991-11-22 | 2007-02-27 | Alcon Laboratories, Inc. | Angiostatic steroids |
| US5272134A (en) * | 1992-03-24 | 1993-12-21 | Erox Corporation | Fragrance compositions and other compositions which contain human pheromones |
| ATE255898T1 (de) * | 1993-06-15 | 2003-12-15 | Pherin Corp | Androstansteroide als neurochemische initiatoren einer veränderung der hypothalamusfunktion beim menschen und verwandte pharmazeutische präparate und verfahren |
| CN1167489A (zh) * | 1994-09-29 | 1997-12-10 | 弗伦有限公司 | 具有诱导下丘脑作用的新的雌甾烯 |
-
1994
- 1994-09-29 US US08/316,435 patent/US5969168A/en not_active Expired - Lifetime
-
1995
- 1995-09-29 NZ NZ294508A patent/NZ294508A/xx unknown
- 1995-09-29 BR BR9509173A patent/BR9509173A/pt unknown
- 1995-09-29 FI FI971314A patent/FI971314L/fi unknown
- 1995-09-29 CZ CZ97925A patent/CZ92597A3/cs unknown
- 1995-09-29 WO PCT/US1995/012538 patent/WO1996010031A1/en not_active Ceased
- 1995-09-29 EP EP95935234A patent/EP0783512A4/en not_active Withdrawn
- 1995-09-29 AU AU37329/95A patent/AU702704B2/en not_active Ceased
- 1995-09-29 RU RU97107006/04A patent/RU2160740C2/ru active
- 1995-09-29 CN CN95196354A patent/CN1057767C/zh not_active Expired - Fee Related
- 1995-09-29 MX MX9702252A patent/MX9702252A/es unknown
- 1995-09-29 HU HU9800293A patent/HUT77665A/hu unknown
- 1995-09-29 KR KR1019970702033A patent/KR970706296A/ko not_active Ceased
- 1995-09-29 PL PL95319606A patent/PL319606A1/xx unknown
- 1995-09-29 CA CA002199043A patent/CA2199043A1/en not_active Abandoned
- 1995-09-29 JP JP8512065A patent/JPH10509692A/ja active Pending
-
1997
- 1997-03-25 NO NO971418A patent/NO971418L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NZ294508A (en) | 1999-02-25 |
| WO1996010031A1 (en) | 1996-04-04 |
| FI971314A7 (fi) | 1997-03-27 |
| NO971418D0 (no) | 1997-03-25 |
| AU3732995A (en) | 1996-04-19 |
| NO971418L (no) | 1997-05-23 |
| EP0783512A4 (en) | 1998-09-02 |
| KR970706296A (ko) | 1997-11-03 |
| RU2160740C2 (ru) | 2000-12-20 |
| EP0783512A1 (en) | 1997-07-16 |
| CZ92597A3 (en) | 1997-09-17 |
| JPH10509692A (ja) | 1998-09-22 |
| PL319606A1 (en) | 1997-08-18 |
| FI971314A0 (fi) | 1997-03-27 |
| FI971314L (fi) | 1997-03-27 |
| CN1166836A (zh) | 1997-12-03 |
| BR9509173A (pt) | 1997-11-25 |
| US5969168A (en) | 1999-10-19 |
| AU702704B2 (en) | 1999-03-04 |
| CN1057767C (zh) | 2000-10-25 |
| HUT77665A (hu) | 1998-07-28 |
| CA2199043A1 (en) | 1996-04-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9702252A (es) | Nuevos androstanos para inducir efectos hipotalamicos. | |
| DE69504071D1 (de) | Turbomaschine | |
| DE69321839D1 (de) | Zusammensetzung für die lymphatische anwendung | |
| ES2196534T3 (es) | Antagonistas del receptor de vitronectina. | |
| DE69501155D1 (de) | Leitgitter für einen kompressor | |
| ITMI951313A0 (it) | Macchina circolare per treccia | |
| ITMI962644A0 (it) | Macchina circolare per treccia | |
| AR019631A1 (es) | Agentes terapeuticos nuevos que modulan receptores de 5-ht. | |
| DE69605103D1 (de) | Bestückungsautomat für bauelemente | |
| DE69620626D1 (de) | Bügeleisen für wäsche | |
| FI941936L (fi) | Pilarikenkä | |
| DE59711509D1 (de) | Schildvortriebsmaschine | |
| DE59803439D1 (de) | Fussmaschine für bassdrum | |
| BR9702153A (pt) | Suporte fibroso para um produto abrasivo que incorpora um tal suporte | |
| KR950026890U (ko) | 와이어 커팅기의 와이어 연결치구 | |
| DE59600007D1 (de) | Bindemittel für textile Flächengebilde | |
| DE59507265D1 (de) | Bestückungsvorrichtung für Spulengatter | |
| TR199500905A2 (tr) | Tetrasiklik triterpenler. | |
| ATA1696A (de) | Diarahmen für grossbildprojektion | |
| IT1286207B1 (it) | Sottoago modificato con relativi organi di azionamento per macchine circolari per calze e calzini | |
| KR960034585U (ko) | 쉐타 편조용 원사 | |
| DE69821070D1 (de) | Programmablauf für Geschirrspülmaschine und Geschirrspülmaschine die einen solchen Ablauf benutzt | |
| NO942253D0 (no) | Maskin for innstöping av anker i betong | |
| KR960029982U (ko) | 구근류 채굴 작업기 | |
| FR2731720B1 (fr) | Ensemble lave-linge |